NYSEConsumer StaplesAgricultural Farm ProductsSnapshot 2026-08-31
Reading BG? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →Intact: The reason to own it still holds.
Bunge Global integrates Viterra to boost growth and synergy. Full-year EPS guidance raised to about $9.25, showing management confidence. The company maintains a cheap valuation with a P/E of 15 versus peers at 19. Free cash flow is negative but improving. Share buyback plans signal capital return focus.
Cash strain raises dilution risks and threatens buyback plans. CEO transition and volatile management may disrupt execution. EPS growth has been mixed despite raised guidance. The recent selloff and soft guidance posture reflect market concerns.
The price is about 10% below our fair value near $122. Analysts expect roughly 11% revenue growth. Our view aligns with consensus but notes risks from cash strain and integration delays.
Breaks if: Buyback program canceled or materially reduced due to cash constraints
Breaks if: EPS falls below $9.25 in FY26
Prolonged leadership instability or key executive departures continue
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
BG represents a cyclical investment with a focus on integration and operational improvements. The current thesis state indicates a watchful approach due to recent mixed financial performance and management volatility.
The market currently prices BG as relatively cheap compared to its peers, with a notable expectations gap. This suggests that investors may be anticipating challenges ahead, particularly given the recent earnings miss.
Management is on track with key priorities, including the integration of the Viterra acquisition and raising adjusted EPS guidance. However, recent financial performance has been neutral, and there is a moderate risk of missing future earnings expectations.
The long-term thesis hinges on the successful integration of the Viterra acquisition and the ability to maintain or improve earnings guidance. Additionally, external factors like inflation and economic conditions will play a crucial role in BG's performance.
The most important moves since the prior daily snapshot.
Yes, our read has weakened. The latest earnings report missed expectations. This miss raises concerns about the company's performance. The company priced a $600 million senior notes offering. This offering provides more financial headroom for future needs. However, the offering is not yet final.
as of 2026-08-31
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Breaks if: Integration progress stalls or synergies fail to materialize by FY26
Complete and integrate the Viterra acquisition to expand global footprint and capabilities, capturing operational and commercial synergies.
Stated as a priority in 6 of last 6 quarters. Management consistently emphasized completing and integrating the Viterra acquisition to expand capabilities and capture synergies. Operational data shows soybean processing volumes increased from 8.1 million metric tons in 2026-Q1 to 11.5 million in 2026-Q2, and segment EBIT grew from $209 million to $804 million, reflecting delivery on integration benefits. The trajectory is delivering as volumes and earnings improved post-acquisition.
“Our expanded global platform did exactly what it was designed to do, capturing opportunities and delivering for customers at both ends of the value chain.”
“We are well equipped to continue serving customers at both ends of the value chain while delivering for all our stakeholders.”
“We completed our transformational combination with Viterra, advanced major growth projects and began to capture operational and commercial synergies.”
“In our first full quarter since closing the Viterra transaction, our combined team delivered strong results leveraging increased footprint and capabilities.”
“In final stage of regulatory process for Viterra transaction, prepared to close quickly once received.”
“In final stage of regulatory approval for our combination with Viterra and prepared to close quickly once received.”
In the next 1 to 3 years, BG's trajectory will depend on management execution and broader economic conditions. Not investment advice.
